TABLE 3.　ANTITUBERCULOSIS MEDICATION, IN VITRO SUSCEPTIBILITY CRITERIA, AND COMMON SIDE-EFFECTS/TOXICITY (1)

TABLE 4.　DOSAGES AND PHARMACOKINETICS OF ANTI-TUBERCULOSIS MEDICATIONS (1)

(*)　4 grams bid for new formulation, Paser^(R)

前ページ　　　目次へ　　　次ページ